Tag: NCDs

Universal Health Coverage
EB 144 IFPMA statement under agenda item 5.8.2 Non-Communicable Diseases
R&D-based biopharmaceutical industry welcomes UN Declaration on NCDs
The R&D-based biopharmaceutical industry welcomes the UN Declaration on NCDs and calls for innovative financing models and multi-sectoral collaboration
Improving flu vaccine uptake for at risk groups
IAEA’s Programme of Action for Cancer Therapy (PACT) Partners with IFPMA on Comprehensive Cancer Control
Access Accelerated - Moving NCD Care Forward
22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable Diseases
Hypertension: putting the pressure on the silent killer
World cancer day: R&D pharmaceutical industry partnerships to enhance access to cancer care
The AFRO Comprehensive Cervical Cancer Prevention and Control Initiative
Women's Cancer Initiative in the Americas
Be Healthy Be Mobile
Assessing the value of treatment for diabetes to patients, the healthcare system, and wider society - A case study on China
Framework for action for the prevention and control of non-communicable diseases
Non-communicable diseases
Improving prevention of women’s cancers in Latin America and The Caribbean
1) Did you know? Improving prevention of women’s cancers in Latin America and The Caribbean
2) Did you know? Improving prevention of women’s cancers in Latin America and The Caribbean
3) Did you know? Improving prevention of women’s cancers in Latin America and The Caribbean
Population attitude to personal health in Thailand
PPP launched to improve prevention of women’s cancers and quality of cancer registries in Latin America and the Caribbean
Partnering to learn more about prevention of non-communicable diseases
Check against delivery – Item 13.3 Prevention and control of non communicable diseases
Bringing psoriasis into the light
NCDs & influenza infographic
The Joint IFRC-IFPMA Reception on the occasion of the 67th World Health Assembly

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance antivirals Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Clinical Trials Code of Practice collaboration Counterfeit Medicines Counterfeits COVID-19 COVID-19 vaccines Dementia Developing World Diabetes Economic footprint Epidemics Ethics Event Highlights Fake Medicines Fakes Falsified Medicines Fight the Fakes Flu Global Health global health security harmonization Health Health Partnerships HIV/AIDS IFPMA IFPMA Assembly IFPMA Statement Immunization Incremental Innovation Influenza Infographic Infographics Innovation Innovation ecosystem Intellectual Property IP Malaria MDGs Medicines Mental and Neurological Disorders NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases Novel Coronavirus (COVID-19) NTDs pandemic Pandemic Influenza Pandemic preparedness pandemics partnership Partnerships Pharma Pharmacovigilance Position Paper Prevention Publications Public Health Quality R&D Regulatory regulatory systems Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Value of Innovation Videos WHA WHO WIPO Women’s Cancers